These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 8881423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Humoral mechanisms in immune neuropathies.
    Koski CL.
    Neurol Clin; 1992 Aug; 10(3):629-49. PubMed ID: 1501599
    [Abstract] [Full Text] [Related]

  • 5. Pathology of inflammatory demyelinating neuropathies.
    Prineas JW.
    Baillieres Clin Neurol; 1994 Apr; 3(1):1-24. PubMed ID: 7921584
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory mediators in demyelinating disorders of the CNS and PNS.
    Hartung HP, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, Toyka KV.
    J Neuroimmunol; 1992 Oct; 40(2-3):197-210. PubMed ID: 1331168
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies.
    Hahn AF.
    Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424
    [Abstract] [Full Text] [Related]

  • 9. Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies.
    Latov N, Renaud S.
    J Neurol Sci; 2004 May 15; 220(1-2):127-9. PubMed ID: 15140620
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Immunopathology of inflammatory neuropathies].
    Oka N.
    Rinsho Shinkeigaku; 1999 Jan 15; 39(1):90-1. PubMed ID: 10377818
    [Abstract] [Full Text] [Related]

  • 14. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.
    Ariga T, Yu RK.
    J Neurosci Res; 2005 Apr 01; 80(1):1-17. PubMed ID: 15668908
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Acquired demyelinating neuropathies].
    Hahn AF.
    Rev Prat; 2000 Apr 01; 50(7):724-30. PubMed ID: 10853551
    [Abstract] [Full Text] [Related]

  • 17. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
    Kusunoki S.
    Rinsho Shinkeigaku; 1999 Jan 01; 39(1):93-5. PubMed ID: 10377820
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The role of complement in autoimmune thyroid disorders].
    Potluková E, Limanová Z.
    Cas Lek Cesk; 2007 Jan 01; 146(3):210-4. PubMed ID: 17419301
    [Abstract] [Full Text] [Related]

  • 20. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G, Lopez PH, Li CY, Mehta NR, Griffin JW, Schnaar RL, Sheikh KA.
    Brain; 2004 May 01; 127(Pt 5):1085-100. PubMed ID: 14985267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.